• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care
Prostate Cancer : Episode 3

Episode 3 - Radium-223 for the Treatment of CRPC

Video

In addition to cytotoxic chemotherapy, immunotherapy, and oral agents that target the androgen pathway, David Crawford, MD, discusses radium-223 as a therapeutic option for the treatment of castration-resistant prostate cancer (CRPC).

Dr Crawford cites the ALSYMPCA clinical trial and explains how the trial tested radium-223 and found that the drug demonstrated several benefits to patients with CRPC. Benefits included increased survival rates, decreased instances of overall pain, and lower numbers of symptomatic skeletal events and fractures, as well as lessened the need for treatment with surgery or radiation.

Related Videos
Dr Sundar Jagannath
Screenshot of a webinar panel discussion with Viet Le, PA-C; Nathan Wong, PhD, MPH; Alison Bailey, MD; and Martha Gulati, MD, MS
Mehmet Oz, MD, MBA
Ayodeji Adegunsoye, MD, PhD, MSc
Marilyn Glassberg, MD
Dr Caroline Vovan
Interview with Miriam Freimer, MD, The Ohio State University Wexner Medical Center
Merrill H. Stewart, MD
Rachel Rohaidy, MD
Related Content
Elena Fenster | Background Image Credit: ipopba - stock.adobe.com

Contributor: Reframing Health Literacy—A Systemic Driver of Equity and Outcomes

July 29th 2025
Article

Improving health literacy is essential for promoting health equity, reducing preventable illness, and making health care more effective.

Read More

Managed Care Cast

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

July 15th 2025
Podcast

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

Listen

Long COVID graphic | Image Credit: Parradee - stock.adobe.com

Long COVID More Common Among Socially Vulnerable Individuals

July 28th 2025
Article

Social risk factors significantly increase the likelihood of developing long COVID, highlighting the urgent need for equitable health care and support systems.

Read More

Managed Care Cast

Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH

July 1st 2025
Podcast

Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.

Listen

Doctor with patient | Image credit: Chinnapong - stock.adobe.com

5 Major Changes the Trump Administration Has Made in Health Care

July 25th 2025
Article

At the 6-month anniversary of the inauguration in January, The American Journal of Managed Care® looks back at the changes made by the Trump administration that could have lasting effects in health care.

Read More

The findings suggest that inhibition of midkine might be a meaningful tool to improve treatment outcomes in SCLC. | Image credit: Pixel-Shot - stock.adobe.com

Midkine May Play Key Role in SCLC

July 24th 2025
Article

New data show midkine expression is heightened in small cell lung cancer, suggesting the growth factor may be an important therapeutic target.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.